Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -184.73% is 66% above its 5-year average of -548.64%, near the high end of its 5-year range (-22996.36%–-8.05%).
17.42% above its 12-month average of -223.69%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2024 (2024-12-31): -65.78%.
EBITDA MARGIN
-184.73%
EBITDA MARGIN AVG TTM
-223.69%
EBITDA MARGIN AVG 3Y
-290.13%
EBITDA MARGIN AVG 5Y
-548.64%
EBITDA MARGIN AVG 10Y
-543.76%
EBITDA MARGIN AVG 15Y
-438.54%
EBITDA MARGIN AVG 20Y
-503.46%
CURRENT VS TTM AVG
+17.42%
CURRENT VS 3Y AVG
+36.33%
CURRENT VS 5Y AVG
+66.33%
CURRENT VS 10Y AVG
+66.03%
CURRENT VS 15Y AVG
+57.88%
CURRENT VS 20Y AVG
+63.31%
Capricor Therapeutics, Inc.
Market Cap
$447.43M
EBITDA Margin
-184.73%
TTM Avg
-223.69%
3Y Avg
-290.13%
5Y Avg
-548.64%
Market Cap
$450.64M
EBITDA Margin
-16.58%
TTM Avg
-87.69%
3Y Avg
-357.20%
5Y Avg
-653.36%
Market Cap
$453.70M
EBITDA Margin
-1349.20%
TTM Avg
-1349.20%
3Y Avg
-1349.20%
5Y Avg
-1349.20%
Market Cap
$428.16M
EBITDA Margin
-232.13%
TTM Avg
-495.69%
3Y Avg
-578.57%
5Y Avg
-532.48%
Market Cap
$471.57M
EBITDA Margin
-3.52%
TTM Avg
-5.19%
3Y Avg
-11.78%
5Y Avg
-23.46%
Market Cap
$416.68M
EBITDA Margin
-107.01%
TTM Avg
-86.79%
3Y Avg
-53.66%
5Y Avg
-431.14%
Market Cap
$478.54M
EBITDA Margin
-31.76%
TTM Avg
-31.76%
3Y Avg
-31.76%
5Y Avg
-31.76%
Market Cap
$415.93M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Capricor Therapeutics, Inc. (CAPR) | $447.43M | -184.73% | -223.69% | -290.13% | -548.64% |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | -16.58% | -87.69% | -357.20% | -653.36% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | -1349.20% | -1349.20% | -1349.20% | -1349.20% |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -232.13% | -495.69% | -578.57% | -532.48% |
| NRC Health (NRC)vs › | $468.31M | 21.99% | 25.40% | 28.98% | 31.97% |
| Cerus Corporation (CERS)vs › | $471.57M | -3.52% | -5.19% | -11.78% | -23.46% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | -107.01% | -86.79% | -53.66% | -431.14% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | -31.76% | -31.76% | -31.76% | -31.76% |
| Carlsmed, Inc. (CARL)vs › | $415.93M | -59.97% | -74.12% | -94.06% | -94.06% |
| Arvinas, Inc. (ARVN)vs › | $481.33M | -41.77% | -67.13% | -207.81% | -270.93% |
Gross Margin
0.0%
EBITDA Margin
-184.7%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-12-31 | -65.78% |
| 2024-09-30 | -559.27% |
| 2024-06-30 | -282.88% |
| 2024-03-31 | -202.46% |
| 2023-12-31 | -8.05% |
| 2023-09-30 | -106.50% |
| 2023-06-30 | -191.26% |
| 2023-03-31 | -266.33% |
| 2022-12-31 | -820.37% |
| 2022-09-30 | -398.40% |
| 2021-06-30 | -2465.17% |
| 2021-03-31 | -12521.93% |
| 2020-12-31 | -7156.26% |
| 2020-09-30 | -22996.36% |
| 2020-06-30 | -6929.26% |
| 2020-03-31 | -1117.18% |
| 2019-12-31 | -648.65% |
| 2019-09-30 | -1115.75% |
| 2019-06-30 | -492.96% |
| 2019-03-31 | -1090.53% |
| 2018-12-31 | -503.44% |
| 2018-09-30 | -1883.98% |
| 2018-06-30 | -1020.92% |
| 2018-03-31 | -912.83% |
| 2017-09-30 | -831.38% |
| 2017-06-30 | -335.36% |
| 2017-03-31 | -400.45% |
| 2016-12-31 | -421.03% |
| 2016-09-30 | -762.63% |
| 2016-06-30 | -502.33% |
| 2016-03-31 | -458.54% |
| 2015-12-31 | -357.00% |
| 2015-09-30 | -309.64% |
| 2015-06-30 | -333.07% |
| 2015-03-31 | -325.35% |
| 2014-12-31 | -132.13% |
| 2014-09-30 | -141.35% |
| 2014-06-30 | -141.10% |
| 2014-03-31 | -113.10% |
| 2013-12-31 | -0.06% |
| 2013-09-30 | -1849.28% |
| 2013-06-30 | -848.15% |
| 2013-03-31 | -611.20% |
| 2012-12-31 | 162.70% |
| 2012-09-30 | -114.67% |
| 2012-03-31 | -392.88% |
| 2011-12-31 | -850.83% |
| 2011-09-30 | -141.97% |
| 2011-06-30 | -253.79% |
| 2007-09-30 | -4569.01% |
| 2007-06-30 | -10424.25% |
| 2003-09-30 | -3.80% |
